Together we will beat cancer

Donate

What can tumours in Tasmanian devils teach us about immunotherapy resistance?

A peculiar type of tumour, in an even more peculiar type of animal, could hold some clues to help scientists overcome immunotherapy resistance in humans.

Read More

Science Surgery: ‘Why doesn’t the immune system attack cancer cells?’

This entry is part 13 of 18 in the series Science Surgery

In this Science Surgery post Millie asks: ‘Why doesn’t the immune system attack cancer cells?’ The short answer is it does! But sometimes it needs a helping hand from exciting new treatments.

Read More

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

Read More

Nobel Prize 2018: How Allison and Honjo turned immune cells against cancer

Dr James Allison and Professor Tasuku Honjo have been given a Nobel Prize for revolutionising our understanding of how the immune system sees cancer.

Read More

Science Surgery: ‘What’s being done to use treatments in different types of cancer?’

This entry is part 7 of 18 in the series Science Surgery

In this Science Surgery post we explore the work being done to use existing treatments in other types of cancer.

Read More

Professor Margaret Frame OBE and her contribution to cancer research

We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research.

Read More

From cancer evolution to targeting faulty genetics – our new fellows

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

Read More

News digest – e-cig inquiry, breast cancer risk, junk food promotions, and… a lack of goodwill?

This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.

Read More

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

Read More

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

Read More